(Q36580633)

English

Review article: induction therapy for patients with active ulcerative colitis

scientific article published on September 2006

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15 August 2017

1 reference

Europe PubMed Central

title

Review article: induction therapy for patients with active ulcerative colitis (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15 August 2017

1 reference

Travis SP

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16939424

retrieved

15 August 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16939424

retrieved

15 August 2017

published in

Alimentary Pharmacology & Therapeutics

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16939424

retrieved

15 August 2017

volume

24 Suppl 1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16939424

retrieved

15 August 2017

page(s)

10-16

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16939424

retrieved

15 August 2017

cites work

Guidelines for the management of inflammatory bowel disease in adults

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03070.X

retrieved

21 January 2018

How effective are the usual treatments for ulcerative colitis?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03070.X

retrieved

21 January 2018

Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03070.X

retrieved

21 January 2018

Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03070.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1365-2036.2006.03070.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16939424

retrieved

15 August 2017

PubMed publication ID

16939424

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16939424

retrieved

15 August 2017

ResearchGate publication ID

6850127

0 references

(Q36580633)

Review article: induction therapy for patients with active ulcerative colitis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)